Uniplan Investment Counsel Inc. Purchases 16,187 Shares of iRadimed Corporation $IRMD

Key Points

• Uniplan Investment Counsel Inc. increased its ownership in iRadimed Corporation by 49.7% in the first quarter, now holding 48,727 shares valued at approximately $2.6 million.
• iRadimed recently declared a quarterly dividend of $0.17, translating to an annualized dividend of $0.68 and a dividend yield of 0.9%.
• The company's shares have experienced significant price movement, with a 52-week range between $44.58 and $74.00, and currently trades at around $71.99.

Uniplan Investment Counsel Inc. increased its holdings in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) by 49.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,727 shares of the medical equipment provider's stock after acquiring an additional 16,187 shares during the period. Uniplan Investment Counsel Inc. owned about 0.38% of iRadimed worth $2,557,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. First Horizon Advisors Inc. boosted its stake in iRadimed by 78.7% in the first quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock worth $27,000 after purchasing an additional 226 shares in the last quarter. US Bancorp DE increased its stake in shares of iRadimed by 132.7% in the first quarter. US Bancorp DE now owns 1,436 shares of the medical equipment provider's stock valued at $75,000 after buying an additional 819 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of iRadimed in the first quarter valued at $78,000. Comerica Bank increased its stake in shares of iRadimed by 21.4% in the first quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock valued at $120,000 after buying an additional 404 shares in the last quarter. Finally, State of Wyoming acquired a new stake in shares of iRadimed in the fourth quarter valued at $149,000. Institutional investors own 92.34% of the company's stock.

Insider Buying and Selling at iRadimed

In other news, Director Monty K. Allen sold 1,102 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total value of $76,148.20. Following the completion of the sale, the director directly owned 19,898 shares in the company, valued at approximately $1,374,951.80. This trade represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 36.80% of the company's stock.

iRadimed Price Performance

Shares of NASDAQ:IRMD traded down $2.27 during midday trading on Friday, reaching $72.00. The company's stock had a trading volume of 13,915 shares, compared to its average volume of 44,304. iRadimed Corporation has a fifty-two week low of $46.86 and a fifty-two week high of $74.43. The company has a market capitalization of $915.84 million, a P/E ratio of 44.44 and a beta of 1.02. The business's fifty day simple moving average is $65.88 and its 200-day simple moving average is $58.35.

iRadimed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Monday, August 18th were paid a $0.17 dividend. The ex-dividend date was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.9%. iRadimed's dividend payout ratio (DPR) is 41.98%.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.